文献速递泌尿生殖PETCT

基于68Ga-PSMA-617 PET/CT的机器学习模型用于前列腺癌诊断与风险评估

Machine learning models for enhanced diagnosis and risk assessment of prostate cancer with 68Ga-PSMA-617 PET/CT.
PubMed 文献 · Eur J Radiol · 2025-03-19

回顾性分析191例经68Ga-PSMA-617 PET/CT检查的前列腺癌或良性前列腺增生患者,提取影像组学特征并用6种机器学习算法预测恶性及不良病理特征,测试集AUC为0.938和0.916,验证集AUC为0.918和0.855,并发现3个影像组学特征与10种蛋白标志物相关。

要点

  • 测试集影像组学模型预测恶性前列腺病变AUC为0.938,预测不良病理特征AUC为0.916。
  • 验证集对应AUC分别为0.918和0.855,模型在风险分层中表现良好。
  • 识别出3个定量影像组学特征和10种与不良病理相关的蛋白分子,二者显著相关。

核心结论

  • 基于68Ga-PSMA-617 PET/CT影像组学特征的机器学习模型在患者分层中表现良好,支持临床风险分层,并揭示影像组学特征与蛋白标志物之间的联系。

研究设计与样本

  • 回顾性研究,纳入191例经68Ga-PSMA-617 PET/CT确诊的前列腺癌或良性前列腺增生患者,从扫描轮廓提取影像组学特征,使用6种机器学习算法预测恶性及不良病理特征,并对39例患者进行蛋白质组学分析。

诊断标准与关键数值

  • 影像组学模型在测试集预测恶性前列腺病变的AUC为0.938,预测不良病理特征的AUC为0.916;验证集对应AUC分别为0.918和0.855。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Prostate cancer (PCa) is highly heterogeneous, making early detection of adverse pathological features crucial for improving patient outcomes. This study aims to predict PCa aggressiveness and identify radiomic and protein biomarkers associated with poor pathology, ultimately developing a multi-omics marker model for better clinical risk stratification.

METHODS: In this retrospective study, 191 patients with PCa or benign prostatic hyperplasia confirmed via 68Ga-PSMA-617 PET/CT scans were analyzed. Radiomic features were extracted from scan contours, and six machine learning algorithms were used to predict malignancy and adverse pathological features like Gleason score, ISUP group, tumor stage, lymph node infiltration, and perineural invasion. Feature selection and dimensionality reduction were performed using minimum redundancy maximum relevance and least absolute shrinkage and selection operator methods. Proteomics analysis on 39 patients identified protein biomarkers, followed by correlation analysis between radiomic features and identified proteins.

RESULTS: The radiomics model showed an AUC of 0.938 for predicting malignant prostate lesions and 0.916 for adverse pathological features in the test set, with validation set AUCs of 0.918 and 0.855, respectively. Three quantitative radiomic features and ten protein molecules associated with adverse pathology were identified, with significant correlations observed between radiomic features and protein biomarkers. Radioproteomic analysis revealed that molecular changes in protein molecules could influence imaging biomarkers.

CONCLUSIONS: The machine learning models based on 68 Ga-PSMA-617 PET/CT radiomic features performed well in stratifying patients, supporting clinical risk stratification and highlighting connections between radiomic characteristics and protein biomarkers.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu W, Tang Y, Qi L, et al. Machine learning models for enhanced diagnosis and risk assessment of prostate cancer with 68Ga-PSMA-617 PET/CT. Eur J Radiol. 2025. PMID: 40147164. doi:10.1016/j.ejrad.2025.112063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。